Next Rosa Impact Webinar

Quantitative Systems Pharmacology in CNS Disorders. Providing value for Pharmaceutical R&D in Neurology and Psychiatry By Hugo Geerts Scientific Liaison Officer In Silico Biosciences Oct 22, 2014 1:00 to 2:00 pm EDT Abstract: CNS Quantitative Systems Pharmacology uses computer-based mechanistic modeling to integrate the biophysically realistic neurophysiology of brain networks, functional imaging of genetics, the pharmacology of drug-receptor interactions, human imaging on the pathological changes in disease, and parametrization with historical clinical data. A computer model for an individual patient ('a human avatar') can be developed, allowing one to address value proposition issues, ranging from target validation over a clinical candidate selection to support in early clinical development. We will show examples of key R&D support in Alzheimer's disease, Parkinson's disease, and schizophrenia. Register for this free webinar at http://www.rosaandco.com/webinar.html. After registering you will receive a confirmation email containing information about joining the webinar. More information about the webinar series, an archive of past webinars, and a list of future webinar speakers may be found at http://www.rosaandco.com/webinar.html Toufigh Gordi Toufigh Gordi, PhD President, PK/PD and Clinical Pharmacology Services Direct: 408-480-7314 Corp: 408-370-9800 Fax: 408-370-9810 [email protected] The information contained in this e-mail message, e-mail message sequence, and/or any enclosures is confidential, and it may be privileged and protected from unauthorized use and/or disclosure. If you are not the intended recipient, any use, dissemination, distribution, or copying is strictly prohibited. If you received this e-mail in error, PLEASE NOTIFY THE SENDER immediately and destroy this message, any enclosures, and any copies of the message and/or the enclosures. Thank you.